Potassium-binding Therapy
Potassium-Binding Therapy is a pharmacotherapeutic intervention belonging to the class of ion-sequestering agents, specifically characterized by its mechanism of binding potassium ions in the gastrointestinal tract to reduce systemic potassium absorption and manage hyperkalemia in patients undergoing dialysis.
29
Publications
2.2K
Citations
138
Authors
80
Institutions
Publications per year
2017–2026
13
Parents
29
Bertram Pitt, Stefan D. Anker, David A. Bushinsky et al. · European Heart Journal · 2011 · 437 citations · Full text
Bertram Pitt, George L. Bakris, David A. Bushinsky et al. · European Journal of Heart Failure · 2015 · 159 citations · Full text
1–5 of 29
138
5
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 138
80
Inserm
Paris, France
7 h-index
12 publications
798 citations

University of Rochester
Rochester, United States
6 h-index
9 publications
2.3K citations
University of Michigan
Ann Arbor, United States
6 h-index
7 publications
1.2K citations
French Clinical Research Infrastructure Network
Toulouse, France
6 h-index
10 publications
320 citations
Université de Lorraine
Nancy, France
6 h-index
12 publications
402 citations
Michigan Medicine
Ann Arbor, United States
4 h-index
4 publications
676 citations
Vifor Pharma (United States)
Somerset, United States
3 h-index
11 publications
340 citations

Wake Forest University
Winston-Salem, United States
2 h-index
2 publications
494 citations
1–8 of 80
Repository · 3 publications · 155 citations
3
h-index
3 publications · 500 citations
3
h-index
NDT · 2 publications · 66 citations
2
h-index
2 publications · 35 citations
2
h-index
AJN · 2 publications · 61 citations
2
h-index
1–5